Chemokine receptor oligomerization: a further step toward chemokine function.

[1]  O. Marín,et al.  Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness , 2011, Neuron.

[2]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[3]  S. Sligar,et al.  Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding* , 2010, The Journal of Biological Chemistry.

[4]  D. Dupré,et al.  Na+/H+ Exchanger Regulatory Factor-1 Is Involved in Chemokine Receptor Homodimer CCR5 Internalization and Signal Transduction but Does Not Affect CXCR4 Homodimer or CXCR4-CCR5 Heterodimer* , 2010, The Journal of Biological Chemistry.

[5]  U. Naumann,et al.  CXCR7 Functions as a Scavenger for CXCL12 and CXCL11 , 2010, PloS one.

[6]  M. Thelen,et al.  Chemokine receptor oligomerization: functional considerations. , 2010, Current opinion in pharmacology.

[7]  R. Franco,et al.  Dynamic Regulation of CXCR1 and CXCR2 Homo- and Heterodimers1 , 2009, The Journal of Immunology.

[8]  Adam J Kuszak,et al.  Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. , 2009, The Journal of biological chemistry.

[9]  M. Parmentier,et al.  Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists* , 2009, The Journal of Biological Chemistry.

[10]  F. Baleux,et al.  CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. , 2009, Blood.

[11]  N. Heveker,et al.  AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties , 2009, Molecular Pharmacology.

[12]  Bruno Antonny,et al.  The apparent cooperativity of some GPCRs does not necessarily imply dimerization. , 2009, Trends in pharmacological sciences.

[13]  Mudit Gupta,et al.  Imaging chemokine receptor dimerization with firefly luciferase complementation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  N. Yamamoto,et al.  Ligand‐independent higher‐order multimerization of CXCR4, a G‐protein‐coupled chemokine receptor involved in targeted metastasis , 2009, Cancer science.

[15]  T. Jin,et al.  Fluorescence Resonance Energy Transfer Imaging Reveals that Chemokine-Binding Modulates Heterodimers of CXCR4 and CCR5 Receptors , 2008, PloS one.

[16]  M. Parmentier,et al.  Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events , 2008, Molecular Pharmacology.

[17]  Tullio Pozzan,et al.  CXCR4–CCR5: A couple modulating T cell functions , 2008, Proceedings of the National Academy of Sciences.

[18]  G. Milligan,et al.  CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer , 2008, The Biochemical journal.

[19]  Mario Mellado,et al.  Ligand stabilization of CXCR4/δ‐opioid receptor heterodimers reveals a mechanism for immune response regulation , 2008, European journal of immunology.

[20]  Marc Parmentier,et al.  Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers* , 2007, Journal of Biological Chemistry.

[21]  Hongjun Jin,et al.  The Human CC Chemokine MIP-1β Dimer Is Not Competent to Bind to the CCR5 Receptor* , 2007, Journal of Biological Chemistry.

[22]  Richard P. Harvey,et al.  Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 , 2007, Proceedings of the National Academy of Sciences.

[23]  Martin Heck,et al.  Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit , 2007, Proceedings of the National Academy of Sciences.

[24]  J. Pin,et al.  Asymmetric conformational changes in a GPCR dimer controlled by G‐proteins , 2006, The EMBO journal.

[25]  C. Combs,et al.  Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.

[26]  T. Handel,et al.  Heterodimerization of CCR2 Chemokines and Regulation by Glycosaminoglycan Binding* , 2006, Journal of Biological Chemistry.

[27]  G. Graham,et al.  Chemokine scavenging by D6: a movable feast? , 2006, Trends in immunology.

[28]  M. Parmentier,et al.  Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers , 2006, Molecular Pharmacology.

[29]  T. Handel,et al.  Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. , 2005, Cytokine & growth factor reviews.

[30]  Graeme Milligan,et al.  The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities* , 2005, Journal of Biological Chemistry.

[31]  Silvia Sebastiani,et al.  A rich chemokine environment strongly enhances leukocyte migration and activities. , 2005, Blood.

[32]  Antonio Lanzavecchia,et al.  T cell costimulation by chemokine receptors , 2005, Nature Immunology.

[33]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[34]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[35]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[36]  Alfonso Valencia,et al.  A framework for computational and experimental methods: Identifying dimerization residues in CCR chemokine receptors , 2005, ECCB/JBI.

[37]  M. Norcross,et al.  Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4 , 2004, Journal of cellular biochemistry.

[38]  P. Toth,et al.  Regulation of CXCR4 Receptor Dimerization by the Chemokine SDF-1α and the HIV-1 Coat Protein gp120: A Fluorescence Resonance Energy Transfer (FRET) Study , 2004, Journal of Pharmacology and Experimental Therapeutics.

[39]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[40]  C. Martínez-A,et al.  Blocking HIV‐1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor , 2004, The EMBO journal.

[41]  Alfonso Valencia,et al.  Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.

[42]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[43]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[44]  Cristina Limatola,et al.  Ligand-independent CXCR2 Dimerization* , 2003, Journal of Biological Chemistry.

[45]  R. Nibbs,et al.  Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. , 2003, Seminars in immunology.

[46]  C. Weber,et al.  Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. , 2003, Blood.

[47]  R. Horuk,et al.  Development and evaluation of pharmacological agents targeting chemokine receptors. , 2003, Methods.

[48]  Y. Yashiro‐Ohtani,et al.  The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3 , 2003, Journal of leukocyte biology.

[49]  C. Rommel,et al.  Strategies for chemokine antagonists as therapeutics. , 2003, Seminars in immunology.

[50]  Gregory J Babcock,et al.  Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.

[51]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[52]  R. Fairchild,et al.  Chemokines: directing leukocyte infiltration into allografts. , 2002, Current opinion in immunology.

[53]  Michel Bouvier,et al.  Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.

[54]  A. Proudfoot.  Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[55]  M. Alizon,et al.  Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine Receptor* , 2001, The Journal of Biological Chemistry.

[56]  Georgios G. Gkoutos,et al.  Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. , 2001, Protein engineering.

[57]  A. Kenworthy,et al.  Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. , 2001, Methods.

[58]  Mario Mellado,et al.  Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.

[59]  L. Mitnaul,et al.  CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells , 2001, Journal of Virology.

[60]  R. Strieter.  Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.

[61]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[62]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[63]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[64]  C. Murdoch,et al.  Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.

[65]  C. Martínez-A,et al.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[67]  J. Cyster,et al.  Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.

[68]  R. N. Campbell.  Assessing the Spread of Engineered TMV , 1999, Science.

[69]  C. Martínez-A,et al.  The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  C. Martínez-A,et al.  Chemokine control of HIV-1 infection , 1999, Nature.

[71]  T. Schall,et al.  Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up‐regulated upon dendritic cell maturation , 1999, European journal of immunology.

[72]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[73]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  F. Sánchez‐Madrid,et al.  Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.

[75]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[76]  D. Littman.  Chemokine Receptors: Keys to AIDS Pathogenesis? , 1998, Cell.

[77]  M. Hitt,et al.  Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis. , 1998, Journal of immunology.

[78]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[79]  M. Baggiolini,et al.  Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.

[80]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[81]  A. Gronenborn,et al.  Three‐dimensional structures of α and β chemokines , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  B. Sykes,et al.  Neutrophil activation by monomeric interleukin-8. , 1994, Science.

[83]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[84]  E. J. Knight,et al.  The route of re-circulation of lymphocytes in the rat , 1964, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[85]  A. Zernecke,et al.  Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice , 2009, Nature Medicine.

[86]  D. Greaves,et al.  The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization , 2008, Molecular Pharmacology.

[87]  J. Shaw,et al.  Chemokine blockers--therapeutics in the making? , 2006, Trends in pharmacological sciences.

[88]  Antonio Alcami,et al.  Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.

[89]  Elias Lolis,et al.  Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.

[90]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[91]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[92]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.